Notably, pathogenic variants in LRRK2 are thought to cause PD through a gain-of-function mechanism leading to increased kinase activity, which impairs endosomal-lysosomal trafficking, promotes neuroinflammation, and affects ciliogenesis in the striatum14. The gene discussed is LRRK2; the disease is Parkinson disease.